Core Viewpoint - NioBay Metals Inc. has increased the maximum gross proceeds of its private placement from C$5,000,000 to C$7,500,000 due to strong investor demand [1] Group 1: Offering Details - The Marketed Offering consists of Units, FT Units, and Charity FT Units, with each Unit comprising one common share and one warrant [2] - The FT Units will be sold at C$0.16 each, while Charity FT Units will be priced at C$0.21 each [8] - Red Cloud Securities Inc. is acting as the sole agent and bookrunner for the Offering, with an option to sell an additional C$1,000,000 in securities [3] Group 2: Use of Proceeds - The net proceeds from the Offering will be used for the exploration and advancement of the James Bay Niobium Project, as well as for working capital and general corporate purposes [4] - Gross proceeds from the sale of FT Shares will be allocated to eligible Canadian exploration expenses related to the James Bay Niobium Project [5] Group 3: Regulatory and Compliance - The Offering will comply with applicable regulatory requirements and will be offered in several Canadian provinces under the Listed Issuer Financing Exemption [6] - The securities will be immediately freely tradeable in Canada, while those not issued under the Listed Issuer Financing Exemption will have a hold period of four months plus one day [7] Group 4: Company Background - NioBay aims to lead in low carbon consumption mining practices and emphasizes the importance of Indigenous community participation in its operations [12] - The company holds a 100% interest in the James Bay Niobium Project and a 72.5% interest in the Crevier Niobium and Tantalum project [12] Group 5: Industry Context - Niobium is a highly resistant metal used in various sectors, enhancing material properties and reducing environmental impacts [13]

Core Viewpoint - NioBay Metals Inc. has announced a private placement agreement with Red Cloud Securities Inc. to raise up to C$5,000,000 for its James Bay Niobium Project and general corporate purposes [1][4]. Group 1: Offering Details - The private placement will consist of Units, FT Units, and Charity FT Units, with each Unit comprising one common share and one warrant [2][3]. - The pricing for the Units is set at C$0.14, FT Units at C$0.16, and Charity FT Units at C$0.21 [8]. - An additional option allows Red Cloud to sell up to C$1,000,000 in any combination of Units, FT Units, and Charity FT Units prior to the closing [3]. Group 2: Use of Proceeds - The net proceeds from the Offering will be allocated to the exploration and advancement of the James Bay Niobium Project, as well as for working capital and general corporate purposes [4]. - Proceeds from the sale of FT Shares will specifically be used for eligible Canadian exploration expenses related to the James Bay Niobium Project [5]. Group 3: Regulatory and Compliance - The Offering will comply with applicable regulatory requirements and will be offered in several Canadian provinces under the Listed Issuer Financing Exemption [6][7]. - The Offering is scheduled to close on December 18, 2025, subject to necessary regulatory approvals [10]. Group 4: Company Overview - NioBay aims to lead in low carbon consumption mining practices while ensuring the participation of Indigenous communities in its operations [12]. - The company holds a 100% interest in the James Bay Niobium Project and a 72.5% interest in the Crevier Niobium and Tantalum project [12]. Group 5: Industry Context - Niobium is a highly valuable metal used in various sectors, enhancing material properties and reducing environmental impacts [13].

Core Points - KALA BIO Inc. experienced a significant stock price increase of 37.87% to $0.88 in after-hours trading, following a regular session close at $0.64, which was a 3.45% increase [1][6] Financing and Agreements - KALA BIO entered into a Securities Purchase Agreement with investor David Lazar to raise up to $6 million through a private placement, as disclosed in an SEC Form 8-K filing [2] - The first closing raised $1.8 million from the sale of 900,000 Series AA Preferred Shares at $2 each, while a second closing is expected to raise $4.2 million through 2.1 million Series AAA Preferred Shares at $2 each, pending stockholder approval [3] Loan Settlement - KALA BIO reached a loan settlement agreement with Oxford Finance LLC, which requires a $2 million cash payment and the issuance of 1.62 million common stock shares [4] - Upon completion of an initial $1 million payment by January 15, 2026, or the stockholder meeting date, and stock issuance, the Loan Agreement balance will be reduced by $7 million [4] Leadership Changes - David Lazar was appointed as Chief Executive Officer and Principal Executive Officer by the Board, effective from the first closing of the financing [5] - Lazar previously served as CEO of Novabay Pharmaceuticals Inc. from August to November [5] Stock Performance - KALA BIO's stock has declined 91.72% year to date, with a 52-week range of $0.61 to $20.58 and a market capitalization of $5.21 million [6] - Benzinga's Edge Stock Rankings indicate a negative price trend for KALA stock across all time frames [6]

Core Insights - NioBay Metals Inc. has announced successful results from its 2025 summer drill campaign at the Crevier niobium and tantalum project, confirming mineralized zones over a strike length exceeding 6 km [1][3][4] - The company plans to conduct a significantly larger pilot test of 140 tonnes, compared to the previous 10-tonne test, and is engaging with potential customers for niobium oxide production [2][3] - The campaign was supported by the Government of Québec, and the results will be used to update resource estimates for the project [3][4] Company Overview - NioBay Metals Inc. holds a 72.5% interest in the Crevier Project, located in Québec, and aims to develop mines with low carbon consumption and responsible environmental practices [1][20] - The company also has a 100% interest in the James Bay Niobium Project in Ontario, emphasizing the importance of Indigenous community participation in its operations [20] Drill Campaign Details - The 2025 drill campaign consisted of 15 holes covering 3,324 meters, designed to verify mineralization continuity [3] - The campaign confirmed the presence of mineralized zones, with results indicating various percentages of Nb2O5 across multiple drill holes [5][7] - Bulk sampling of over 140 tonnes of rock has been completed for further mineralogical testing [4][6] Mineralization Results - The drill results showed significant intercepts of niobium and tantalum, with various lengths and grades reported [5][8] - Notable intercepts include lengths of up to 19.85 meters with Nb2O5 grades reaching 0.3541% [5][14] - The results will contribute to a comprehensive resource estimate update for the Crevier Project [3][4] Future Plans - NioBay intends to utilize the winter season to advance work on the James Bay Niobium property while continuing discussions with potential customers for niobium oxide [2][3] - The company is focused on producing materials that meet the specific needs of battery manufacturers, indicating a strategic direction towards the energy sector [2][3]

Revenue Performance - Product revenue increased by $0.5 million, or 100%, to $0.5 million for the three months ended September 30, 2025, with revenue derived from the wound care business sold to a Chinese distributor[216] - Product revenue increased by $0.5 million, or 100%, to $0.5 million for the nine months ended September 30, 2025, with revenue from the wound care business sold to a Chinese distributor[225] Expenses - General and administrative expenses decreased by $0.5 million, or 29%, to $1.2 million for the three months ended September 30, 2025, primarily due to reduced outside services costs related to strategic initiatives[217] - General and administrative expenses rose by $0.2 million, or 3%, to $5.8 million for the nine months ended September 30, 2025, primarily due to increased outside services costs related to strategic initiatives[226] - Total operating expenses decreased by $405 thousand, or 24%, to $1.298 million for the three months ended September 30, 2025[214] - Total operating expenses increased by $868 thousand, or 15%, to $6.5 million for the nine months ended September 30, 2025[224] Net Income and Loss - Net loss from continuing operations was $1.333 million for the three months ended September 30, 2025, a decrease of $521 thousand, or 28%, compared to the prior year[214] - Net cash used in operating activities from continuing operations was $6.2 million for the nine months ended September 30, 2025, primarily due to a net loss from continuing operations of $6.6 million[233] - Net income from discontinued operations decreased by $602 thousand, or 94%, to $40 thousand for the three months ended September 30, 2025[214] - Net income from discontinued operations increased significantly to $11.1 million for the nine months ended September 30, 2025, compared to $841 thousand in the same period of 2024, representing a 1,213% increase[224] Asset Impairment - The Company recorded an impairment of $87 thousand for long-lived assets during the three months ended September 30, 2025[218] - The company recorded an impairment of long-lived assets totaling $676 thousand during the nine months ended September 30, 2025[227] Cash and Financing - Cash and cash equivalents increased to $2.3 million as of September 30, 2025, compared to $430 thousand as of December 31, 2024[232] - Net cash used in financing activities from continuing operations was $3.2 million for the nine months ended September 30, 2025, including $2.0 million in cash payments to repurchase outstanding warrants[236] Compliance and Future Outlook - The Company received notification from NYSE American on April 18, 2024, regarding non-compliance with stockholders' equity requirements, which was later resolved by October 20, 2025[205][207] - The Company believes existing cash and cash equivalents will be sufficient to meet planned operating expenses at least through November 7, 2026[208] - The Avenova Asset Divestiture and PhaseOne Divestiture were completed in January 2025, impacting the financial results significantly[205][214] - The Company is evaluating opportunities within emerging financial infrastructure and network-based markets, including select blockchain-based assets[204] Tax and Off-Balance Sheet Arrangements - The company had net operating loss carryforwards of $153.7 million for federal income tax purposes as of December 31, 2024[239] - The company has no off-balance sheet arrangements as of September 30, 2025[242]

Core Points - NovaBay Pharmaceuticals has regained compliance with the NYSE American's continued listing standards as of October 20, 2025 [1][4] - The company was previously notified of non-compliance on April 18, 2024, and May 28, 2024, due to insufficient stockholders' equity [2] - NovaBay raised approximately $6.0 million through the issuance of pre-funded warrants and an additional $2.15 million from the sale of Series E non-voting convertible preferred stock, bringing its stockholders' equity above the required $6 million [3] Company Background - NovaBay Pharmaceuticals focuses on the development and sale of scientifically created and clinically proven products in eyecare, wound care, and skin care [5]

Core Insights - NioBay Metals Inc. has announced significant progress in its Crevier niobium and tantalum project, supported by a grant from the Mining Exploration Support Program for Critical and Strategic Minerals [1][5] - The company has successfully completed metallurgical work demonstrating the niobium-tantalum concentration process on a pilot scale, utilizing nearly 10 million tons of ore [2][5] - The results indicate a potential for further improvement in the extraction process, with plans for a second pilot project to process 145 million tons of ore [4][5] Project Details - The Crevier Project is located approximately 50 km north of Girardville, Quebec, and is situated in the ancestral territory of the Pekuakamiulnuatsh First Nation [1][9] - The funded project aimed to test the robustness of the process flowsheet for extracting niobium and tantalum oxides from the Crevier deposit [2] Results and Performance - The pilot project achieved a peak recovery rate of 84.6% Nb2O5, with an average recovery of 65% during the production of 17 kg of concentrate at 32% Nb2O5 [8] - Compared to laboratory tests conducted in 2012, the final Nb2O5 content of the concentrate improved by 56%, increasing from 20.3% to 36% [8] Future Plans - The company is planning a second pilot project to further enhance production capabilities and market additional products [5] - The final report from SGS regarding the current pilot will be filed on SEDAR once available [4] Company Vision - NioBay aims to lead in the development of low-carbon mines and responsible environmental practices, emphasizing the importance of Indigenous community participation [7] - The company holds a 100% interest in the James Bay Niobium project and a 72.5% interest in the Crevier project [9] Industry Context - Niobium is a highly valuable metal used in various applications across mobility, structural, and energy sectors, enhancing material properties and reducing environmental impact [10]

Core Points - NioBay Metals Inc. has received a new exploration permit for the James Bay Niobium Project from the Ontario government, allowing for the resumption of drilling activities [1][2] - The new exploration campaign will address community concerns regarding water management by modifying the drilling pattern [2] - The company emphasizes the importance of involving the local Moose Cree First Nation community in the planning and execution of the exploration work [4][6] Permits and Work - The new exploration permit is valid for three years and will enable the completion of a drilling campaign that was previously suspended [2] - The drilling campaign will require helicopter-borne operations and strict management of water and drilling mud, which were successfully implemented in the last campaign [2] Community Engagement - NioBay acknowledges the James Bay Niobium Project is part of Treaty 9 and respects the rights and interests of the Moose Cree First Nation [3] - The company prioritizes the consent and participation of Indigenous communities in its operations [6] Company Overview - NioBay aims to lead in the development of low-carbon mines and responsible environmental practices [6] - The company holds a 100% interest in the James Bay Niobium project and a 72.5% interest in the Crevier niobium and tantalum project [6] About Niobium - Niobium is a ductile and malleable metal known for its corrosion resistance and is used in various sectors including mobility, structural, and energy [7] - The addition of niobium to materials enhances their efficiency and reduces environmental impact [7]

Market Overview - U.S. stock futures are showing declines due to uncertainties from the government shutdown, with Dow Jones Industrial Average futures down 322 points (0.69%), S&P 500 futures down 54.50 points (0.81%), and Nasdaq 100 futures down 31 points (0.20%) [1][4][15] - The ongoing government shutdown has created market uncertainty, leading to possible delays in economic data and concerns over fiscal policy [1][16] Major Stock Movements - Major tech stocks such as Apple, Alphabet, Meta, Amazon, and Nvidia experienced small declines, while Nike shares rose approximately 3% after reporting unexpected first-quarter revenue growth [2][15] - Lithium Americas surged 39% following a 5% stake acquisition by the U.S. Department of Energy, indicating strong investor interest in the energy sector [2][7] Investor Sentiment - The market reflects a mix of cautious trading in large-cap tech and sharp rallies in select growth-focused companies, with investors closely monitoring these stocks for potential opportunities amid heightened uncertainty [3][16] - The 10-year U.S. Treasury yield increased to 4.16%, signaling cautious investor sentiment, while gold futures rose 0.5%, trading near $3,894 an ounce, as investors sought safer assets [7][16] Individual Stock Performance - Apple (AAPL) is trading slightly higher at $254.63, with a minimal change of +0.2 (+0.08%) and a market cap of $3.78 trillion [11] - Alphabet (GOOGL) shares are down approximately 0.4%, reflecting broader tech weakness [14] - Meta Platforms (META) shares declined by about 0.5% amid profit-taking [14] - Amazon (AMZN) is facing modest losses of around 0.4% due to risk aversion in tech sectors [14] - Nvidia (NVDA) shares are down approximately 0.5%, pressured by profit-taking and broader tech pullback [15]

Market Overview - U.S. stocks traded lower, with the Dow Jones falling more than 100 points, down 0.26% to 46,195.25, NASDAQ down 0.21% to 22,544.07, and S&P 500 down 0.17% to 6,649.65 [1] - Health care shares increased by 0.8%, while energy stocks decreased by 1.7% [1] Company Performance - Paychex (NASDAQ: PAYX) stock fell around 4% after reporting fiscal Q1 2026 results, with sales growth of 17% year-over-year to $1.540 billion, exceeding analyst estimates of $1.538 billion [2] - Adjusted EPS of $1.22 beat the consensus estimate of $1.21, and the company raised its fiscal 2026 adjusted EPS guidance to $5.43-$5.53, compared to the analyst consensus of $5.45 [2] Commodity Market - Oil prices fell by 1.8% to $62.33, while gold prices rose by 0.5% to $3,875.40 [4] - Silver decreased by 0.4% to $46.825, and copper fell by 0.5% to $4.8680 [4] International Markets - European shares were mostly higher, with the eurozone's STOXX 600 gaining 0.2% and Spain's IBEX 35 Index rising 0.8% [5] - Asian markets closed mixed, with Japan's Nikkei 225 down 0.25% and Hong Kong's Hang Seng up 0.87% [6] Economic Indicators - The Dallas Fed's general business activity index fell 12 points to -5.6 in September [7] - U.S. job openings rose by 19,000 to 7.227 million in August [10] - The Chicago Business Barometer declined to 40.6 in September from 41.5 in the previous month, below market expectations of 43 [10] - The S&P CoreLogic Case-Shiller Home Price Index increased by 1.8% year-over-year in July, while the FHFA house price index declined by 0.1% from the previous month [10] Stock Movements - Zhengye Biotechnology Holding Limited (NASDAQ: ZYBT) shares surged 70% to $3.72, while Beneficient (NASDAQ: BENF) shares rose 62% to $0.5898 after reporting fourth-quarter results [8] - Sunrise New Energy Co., Ltd. (NASDAQ: EPOW) shares increased by 52% to $1.37 following a patent grant [8] - Erayak Power Solution Group Inc. (NASDAQ: RAYA) shares dropped 45% to $4.6888, and NovaBay Pharmaceuticals, Inc. (NYSE: NBY) fell 13% to $1.35 [8]